Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2017

12.06.2017 | Epidemiology

Incidence and treatments of DCIS in octogenarians: grade matters

verfasst von: Erin P. Ward, Anna Weiss, Sarah L. Blair

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study is to better characterize the current incidence and treatment patterns of DCIS in women greater than 80 years of age (>80) and to evaluate the effect of grade on treatment efficacy.

Methods

Retrospective observational study of women diagnosed with single primary DCIS from 2000 to 2012 in SEER. Statistics including incidence, multivariable Cox proportional hazards model and subset analysis were performed.

Results

42,899 female patients with DCIS were identified, 2566 (5.98%) were >80. Incidence of DCIS in the less than 80 (<80) cohort was 8 per 100,000 and 11.7 per 100,000 for >80. >80 patients have a similar incidence of high grade DCIS (9.8%) as compared to <80 cohort (10.7%, P = 0.246). Compared to the <80 population the >80 population received significantly less surgery (97 vs. 92%, P < 0.001) and radiation (22 vs. 47%, P < 0.001). Although on multivariate analysis surgery did not provide a survival benefit for >80 population, it conveyed a survival benefit for high grade DCIS (HR 0.14, 95% CI 02–0.68) that was not observed for low grade DCIS (HR 0.46, 95% CI 0.1–2.03).

Conclusions

Patients over 80 years of age have a relatively high incidence of DCIS and receive low relative rates of treatment. Although surgery does not provide a survival benefit for all patients over 80, it does provide a significant survival benefit for patients with high grade DCIS. Our results suggest that perhaps the biology of the DCIS, not the age of the patient should direct who warrants treatment.
Literatur
1.
Zurück zum Zitat Estevez LG, Alvarez I, Segui MA, Munoz M, Margeli M, Miro C, Rubio C, Lluch A, Tusquets I (2010) Current perspectives of treatment of ductal carcinoma in situ. Cancer Treat Rev 36(7):507–517CrossRefPubMed Estevez LG, Alvarez I, Segui MA, Munoz M, Margeli M, Miro C, Rubio C, Lluch A, Tusquets I (2010) Current perspectives of treatment of ductal carcinoma in situ. Cancer Treat Rev 36(7):507–517CrossRefPubMed
3.
Zurück zum Zitat Cheung S, Booth ME, Kearins O, Dodwell D (2014) Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS). Breast 23(6):807–811CrossRefPubMed Cheung S, Booth ME, Kearins O, Dodwell D (2014) Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS). Breast 23(6):807–811CrossRefPubMed
4.
Zurück zum Zitat Benson JR, Jatoi I, Toi M (2016) Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Lancet Oncol 17(10):e442–e451CrossRefPubMed Benson JR, Jatoi I, Toi M (2016) Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Lancet Oncol 17(10):e442–e451CrossRefPubMed
5.
Zurück zum Zitat Merrill AL, Esserman L, Morrow M (2016) Clinical decisions. Ductal carcinoma in situ. N Engl J Med 374(4):390–392CrossRefPubMed Merrill AL, Esserman L, Morrow M (2016) Clinical decisions. Ductal carcinoma in situ. N Engl J Med 374(4):390–392CrossRefPubMed
6.
Zurück zum Zitat Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J et al (2015) Addressing overtreatment of screen detected DCIS: the LORIS trial. Eur J Cancer 51(16):2296–2303CrossRefPubMed Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J et al (2015) Addressing overtreatment of screen detected DCIS: the LORIS trial. Eur J Cancer 51(16):2296–2303CrossRefPubMed
7.
Zurück zum Zitat de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ (2011) Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 33:111–121CrossRefPubMedPubMedCentral de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ (2011) Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 33:111–121CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Silverstein MJ, Lagios MD (2015) Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/Van Nuys (USC/VNPI) prognostic index. Breast J 21(2):127–132CrossRefPubMed Silverstein MJ, Lagios MD (2015) Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/Van Nuys (USC/VNPI) prognostic index. Breast J 21(2):127–132CrossRefPubMed
9.
Zurück zum Zitat Patani N, Khaled Y, Al Reefy S, Mokbel K (2011) Ductal carcinoma in situ: an update for clinical practice. Surg Oncol 20(1):e23–e31CrossRefPubMed Patani N, Khaled Y, Al Reefy S, Mokbel K (2011) Ductal carcinoma in situ: an update for clinical practice. Surg Oncol 20(1):e23–e31CrossRefPubMed
10.
Zurück zum Zitat Sagara Y, Mallory MA, Wong S, Aydogan F, DeSantis S, Barry WT, Golshan M (2015) Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg 150(8):739–745CrossRefPubMed Sagara Y, Mallory MA, Wong S, Aydogan F, DeSantis S, Barry WT, Golshan M (2015) Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg 150(8):739–745CrossRefPubMed
11.
Zurück zum Zitat Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ (2011) Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat 129(1):165–173CrossRefPubMed Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ (2011) Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat 129(1):165–173CrossRefPubMed
12.
Zurück zum Zitat Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR (1999) Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA 282(22):2156–2163CrossRefPubMed Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR (1999) Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA 282(22):2156–2163CrossRefPubMed
13.
Zurück zum Zitat Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285(21):2750–2756CrossRefPubMed Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285(21):2750–2756CrossRefPubMed
14.
Zurück zum Zitat Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V (1993) Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270(20):2444–2450CrossRefPubMed Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V (1993) Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270(20):2444–2450CrossRefPubMed
15.
Zurück zum Zitat Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314(15):1599–1614CrossRefPubMedPubMedCentral Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314(15):1599–1614CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Corbelli J, Borrero S, Bonnema R, McNamara M, Kraemer K, Rubio D, Karpov I, McNeil M (2014) Physician adherence to U.S. preventive services task force mammography guidelines. Womens Health Issues 24(3):e313–e319CrossRefPubMed Corbelli J, Borrero S, Bonnema R, McNamara M, Kraemer K, Rubio D, Karpov I, McNeil M (2014) Physician adherence to U.S. preventive services task force mammography guidelines. Womens Health Issues 24(3):e313–e319CrossRefPubMed
17.
Zurück zum Zitat Surveillance Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov/) Research Data (1973–2013) National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission Surveillance Epidemiology, and End Results (SEER) Program (http://​www.​seer.​cancer.​gov/​) Research Data (1973–2013) National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission
18.
Zurück zum Zitat Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, Humphrey L (2009) Screening for breast cancer: systematic evidence review update for the US preventive services task force. Ann Intern Med 151:727–737CrossRefPubMedPubMedCentral Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, Humphrey L (2009) Screening for breast cancer: systematic evidence review update for the US preventive services task force. Ann Intern Med 151:727–737CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G (2008) Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482–2488CrossRefPubMed Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G (2008) Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482–2488CrossRefPubMed
20.
Zurück zum Zitat Wang SY, Shamliyan T, Virnig BA, Kane R (2011) Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat 127(1):1–14CrossRefPubMed Wang SY, Shamliyan T, Virnig BA, Kane R (2011) Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat 127(1):1–14CrossRefPubMed
21.
Zurück zum Zitat Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, Housman MG, Escarce JJ (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21(7):1383–1389CrossRefPubMed Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, Housman MG, Escarce JJ (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21(7):1383–1389CrossRefPubMed
Metadaten
Titel
Incidence and treatments of DCIS in octogenarians: grade matters
verfasst von
Erin P. Ward
Anna Weiss
Sarah L. Blair
Publikationsdatum
12.06.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2017
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4330-5

Weitere Artikel der Ausgabe 2/2017

Breast Cancer Research and Treatment 2/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.